Inamed's new President and CEO Babbitt brings experience leading companies through acquisition.
This article was originally published in The Gray Sheet
INAMED's NEW PRESIDENT AND CEO RICHARD BABBITT brings experience in leading companies through the process of being acquired. Announcing Babbitt's appointment Jan. 23, McGhan parent Inamed highlights the fact that he led four separate companies (American Safety Equipment, B.I. Industries, Welsh Manufacturing, and Medical Supply Co.) during the time that they were acquired. Babbitt currently serves as president and CEO of privately held, Los Angeles-based DNA Technologies, and also has served as president and general manager of Ben Hogan Group.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.